<p>Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.</p>

Daniel Ives is the founder and CEO of Shift Bioscience, an early-stage longevity biotechnology company developing anti-aging drugs based on mitochondrial pathways and a single-cell epigenetics discovery platform.

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com

Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).

Business

Entrepreneurship

Investing

A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).

Share #007: Daniel Ives (Shift Bioscience) - April 1st, 2021

Sign up to save your podcasts

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021